Our results showed that HO-1-SIRT1 axis salvaged endothelial dysfunction by modulating signaling and survival pathways to improve NAFLD-induced CVDs. The gene discussed is HMOX1; the disease is metabolic dysfunction-associated steatotic liver disease.